| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/03/2009 | US7498045 Biodegradable polymeric nanocapsules and uses thereof |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 02/26/2009 | WO2009026306A2 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 02/26/2009 | WO2009026292A1 Dosing methods for treating disease |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009024980A2 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 02/26/2009 | WO2009024585A2 Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis |
| 02/26/2009 | WO2009024445A1 Antibodies against human cytomegalovirus (hcmv) |
| 02/26/2009 | WO2009024026A1 Gastrodia elata polysaccharide, its sulfated derivative and their preparation and use |
| 02/26/2009 | WO2009023918A1 Method of producing plant extract formulations |
| 02/26/2009 | WO2009009531A3 Pyrimidinecarboxamide derivatives for the treatment of hiv infections |
| 02/26/2009 | WO2009003493A3 Mhc multimers, methods for their generation, labeling and use |
| 02/26/2009 | WO2008156853A3 Inhibition of filovirus entry into cells and uses thereof |
| 02/26/2009 | WO2008145759A9 New silver(i) compounds and their use in pharmaceutical compositions for the treatment, prophylaxis and prevention of infections |
| 02/26/2009 | WO2008116194A3 Blockers of pore-forming virulence factors and their use as anti-infectives |
| 02/26/2009 | WO2008097364A3 Use of oritavancin for prevention and treatment of anthrax |
| 02/26/2009 | WO2008088581A3 Liposome treatment of viral infections |
| 02/26/2009 | WO2008073961A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | US20090055975 Plant virus transmission inhibitor and methods |
| 02/26/2009 | US20090054528 Bridged polycyclic compound based compositions for coating oral surfaces in pets |
| 02/26/2009 | US20090054501 Azole compounds used as tuberculostatic and leishmanicide agents |
| 02/26/2009 | US20090054488 Isomigrastatin Analogs In The Treatment Of Cancer |
| 02/26/2009 | US20090054477 4-thio substituted quinoline and naphthyridine compounds |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054452 Thienopyridine Derivatives and the Use Thereof as Hsp90 Modulators |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054446 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054389 Topical Composition Comprising an Antibacterial Substance |
| 02/26/2009 | US20090054380 Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054362 Compounds |
| 02/26/2009 | US20090054355 Proliferation Inhibitor Of Helicobacter Pylori Including Alpha-N-Acetyl-Glucosaminyl Bond-Containing Monosaccharide Derivatives |
| 02/26/2009 | US20090054345 Template-Fixed Beta-Hairpin Peptidomimetics With Protease Inhibitory Activity |
| 02/26/2009 | US20090054344 Anti-angiogenic proteins and fragments and methods of use thereof |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054322 Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions |
| 02/26/2009 | US20090054321 Polypeptides and use thereof |
| 02/26/2009 | US20090054317 Polyvalent inhibitors of pathogens |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053808 Compositions and methods for inhibiting the expression of anti-apoptopic genes |
| 02/26/2009 | US20090053336 Method and Formulations for Treating Candidiasis Using Morinda Citrifolia |
| 02/26/2009 | US20090053335 Herbal compositions for the inhibition of human immunodeficiency virus (hiv) |
| 02/26/2009 | US20090053325 Method of Controlling Floating Virus Infection |
| 02/26/2009 | US20090053305 Pharmaceutical Formulations |
| 02/26/2009 | US20090053299 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 02/26/2009 | US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/26/2009 | US20090053294 Anti Mineralocorticoid Therapy of Infection |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053291 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 02/26/2009 | US20090053278 Anti-microbial compositions and devices and methods of using the same |
| 02/26/2009 | US20090053266 Apicomplex vaccine strains of a family of sarcocystidae |
| 02/26/2009 | US20090053264 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 02/26/2009 | US20090053263 Inhibitors of Enveloped Virus Infectivity |
| 02/26/2009 | US20090053261 Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
| 02/26/2009 | US20090053258 Assays for diagnosis of tuberculosis and uses thereof |
| 02/26/2009 | US20090053255 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053251 Dendritic Cell Compositions and Methods |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053245 Pharmacokinetics and Efficacy of Anti-Angiogenic Drugs and Drugs Treating Diseases of the Blood |
| 02/26/2009 | US20090053244 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 02/26/2009 | US20090053243 Anti-IgSF4 Antibody and Utilization of the Same |
| 02/26/2009 | US20090053242 Thrombopoietic compounds |
| 02/26/2009 | US20090053240 Novel Immunoglobulin Insertions, Deletions and Substitutions |
| 02/26/2009 | US20090053239 ACACS As Modifiers of the IGF Pathway and Methods of Use |
| 02/26/2009 | US20090053237 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/26/2009 | US20090053228 Lawsonia intracellularis subunit vaccines |
| 02/26/2009 | US20090053225 Recombinant antibodies against cd55 and cd59 and uses thereof |
| 02/26/2009 | US20090053220 Methods and compositions for the inhibition of hiv infection of t cells |
| 02/26/2009 | US20090053218 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 02/26/2009 | US20090053204 Functional Genomic Pore Assay For Mixed Cell Populations |
| 02/26/2009 | US20090053201 Using variation in DNA polymerase sequence as diagnostic indicator of adefovir or tenofovir resistance in virus; viricides |
| 02/26/2009 | US20090053187 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 02/26/2009 | US20090053179 Method for using liberated dormant bacteriophage and environmental stress to reduce infectious bacteria |
| 02/26/2009 | US20090053177 Protein-polymer conjugates |
| 02/26/2009 | US20090053175 Substitute pyrrolidine derivatives |
| 02/26/2009 | US20090053172 Heterocyclic compounds as ccr5 antagonists |
| 02/26/2009 | US20090053171 Treatment of cellular proliferative disorders |
| 02/26/2009 | US20090053149 nonionic surfactant such as Tyloxapol in a sterile aqueous solution of an antimicrobial such as an antibiotic; phosphatide-free; aerosol drug delivery to lungs |
| 02/26/2009 | US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells |
| 02/26/2009 | DE202008000653U1 Zusammensetzung zur Steigerung der Immunabwehr und zur Behandlung von Erkältungskrankheiten Composition for enhancing the immune system and for the treatment of colds |
| 02/26/2009 | CA2734710A1 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 02/26/2009 | CA2707521A1 Imidazopyrazine compounds |
| 02/26/2009 | CA2701606A1 Antifungal agents |
| 02/26/2009 | CA2697020A1 Method of producing plant extract formulations |
| 02/26/2009 | CA2696753A1 Antiinfective flavononol compounds and methods of use thereof |
| 02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2028186A2 Hepatitis C inhibitor tri-peptides |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027873A1 One dose vaccination with mycoplasma hyopneumoniae |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2027850A1 Pharmaceutical compositions containing voriconazole |
| 02/25/2009 | EP2027155A2 Human binding molecules having killing activity against staphylococci and uses thereof |